Supplements for Glaucoma: Neuroprotection and IOP Support

Glaucoma is a group of optic neuropathies characterized by progressive loss of retinal ganglion cells and their axons, leading to irreversible visual field damage. Intraocular pressure (IOP) is the primary modifiable risk factor, and lowering it with drops, laser, or surgery is the cornerstone of treatment. However, optic nerve damage can continue even when IOP is well controlled, which has driven interest in neuroprotective and vascular strategies. Supplements cannot replace prescribed glaucoma treatment, but several nutrients show enough evidence to warrant consideration as adjuncts under ophthalmologic supervision.

Ginkgo Biloba: Circulation and Neuroprotection

Ginkgo biloba extract (EGb 761, standardized to 24% flavone glycosides and 6% terpene lactones) is the most studied supplement for glaucoma. Its mechanisms are relevant: it improves ocular blood flow by inhibiting platelet-activating factor and promoting vasodilation, and it has direct neuroprotective effects through antioxidant and mitochondrial-stabilizing properties.

A randomized controlled trial published in Ophthalmology found that 40 mg of EGb 761 three times daily (120 mg total) over four weeks significantly improved pre-existing visual field damage in normal-tension glaucoma patients. Normal-tension glaucoma, where optic nerve damage occurs despite normal IOP, is thought to have a vascular component, making ginkgo's circulation effects particularly relevant. Multiple smaller studies have confirmed improved ocular blood flow velocity on color Doppler imaging with ginkgo supplementation. The standard dose is 120 mg per day of standardized extract taken with food. Ginkgo can inhibit platelet aggregation, so patients on anticoagulants or antiplatelet drugs should discuss use with their physician.

Omega-3 Fatty Acids

Omega-3 fatty acids (EPA and DHA) affect glaucoma through several pathways. They reduce systemic inflammation, support the trabecular meshwork (the tissue through which aqueous humor drains), and may have direct neuroprotective effects on retinal ganglion cells. Epidemiological studies show inverse associations between omega-3 intake and glaucoma prevalence. Experimental models demonstrate that DHA is highly concentrated in retinal ganglion cell membranes and that adequate DHA supports cell survival under pressure stress.

A pragmatic dose of 1 to 2 g combined EPA and DHA daily from fish oil is reasonable. Triglyceride-form omega-3s (found in high-quality fish oil, as opposed to ethyl ester forms) have meaningfully better absorption. Choose products that have been third-party tested for oxidation and heavy metals.

Magnesium: Vasospasm and IOP

Magnesium deficiency is associated with vasospasm of ocular vessels and is more common in normal-tension glaucoma patients who have a vasospastic tendency (also manifesting as cold hands, low blood pressure, and migraines). Magnesium acts as a calcium channel antagonist, reducing vasospastic episodes that may compromise optic nerve perfusion.

A double-blind RCT testing 300 mg of magnesium daily for one month in normal-tension glaucoma patients found significant improvements in peripheral vasospasm and some visual field parameters. Magnesium glycinate or malate at 200 to 400 mg before bed is well tolerated and also supports sleep, which is relevant given that IOP is elevated during the night in supine position.

Alpha-Lipoic Acid

Alpha-lipoic acid (ALA) is a mitochondrial antioxidant that is both water- and fat-soluble, allowing it to work throughout the cell. Retinal ganglion cells are highly vulnerable to oxidative stress given their high metabolic demand and length of axons traveling to the brain. ALA regenerates vitamins C and E and boosts glutathione, making it a potent synergistic antioxidant.

A Russian study using 150 mg of ALA daily for two months in open-angle glaucoma patients showed improvements in visual function parameters compared to placebo. The R-form of ALA is more bioavailable than the racemic S-form found in most cheap supplements. Doses of 300 to 600 mg of R-ALA or 600 to 1200 mg of racemic ALA are used in clinical contexts. ALA can reduce blood glucose slightly, which is worth knowing in diabetic patients.

Vitamin D

Low vitamin D levels are associated with elevated IOP and glaucoma risk in population studies. Vitamin D receptors are present in trabecular meshwork cells, and vitamin D appears to regulate aqueous humor dynamics and reduce trabecular meshwork inflammation. Correcting deficiency to serum levels above 40 ng/mL is a reasonable baseline measure for anyone with glaucoma risk factors.

FAQ

Q: Can supplements replace glaucoma eye drops?

Absolutely not. Prescribed IOP-lowering therapy is the standard of care with decades of evidence behind it. Supplements are at best adjuncts that may support optic nerve health through vascular and antioxidant mechanisms. Never stop or reduce prescribed glaucoma medications without your ophthalmologist's guidance.

Q: Who is most likely to benefit from ginkgo for glaucoma?

Patients with normal-tension glaucoma or those with a known vascular component to their disease (vasospasm, migraines, low blood pressure) have the most theoretical benefit. Patients with high-pressure glaucoma that is well controlled on drops have less evidence supporting ginkgo specifically.

Q: Is it safe to take multiple supplements for glaucoma simultaneously?

Most of these supplements (ginkgo, omega-3, magnesium, vitamin D, ALA) can be combined, but ginkgo and omega-3 both affect platelet function and should be used cautiously with blood thinners. Discuss your full supplement list with both your ophthalmologist and primary care physician.

Related Articles

• Supplements for Glaucoma: Neuroprotection and Eye Pressure Support
• AREDS2 Supplement Formula: Complete Guide for AMD
• Astaxanthin for Eye Health: The Powerful Marine Antioxidant
• Bilberry for Eye Health: Ancient Berry, Modern Evidence
• Bilberry for Eye Health: Benefits, Dosing, and Research Evidence

Track your supplements in Optimize.